Vaccine Market - Vaccine Exports From Belgium Seen Growing, Totaling $10,526M in 2014

Pharmaceuticals, Medicinal Chemical And Botanical Products July 08, 2015
Author: Alexander Romanenko
Chief Executive Officer

vaccine market

Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported 6,199 tonnes of vaccines for human medicine totaling $10,526M, 39% over the previous year. Its primary trading partner was France, where it supplied 30.9% of its total vaccine for human medicine exports in value terms, accounting for 83.3% of total French imports.

From 2007 to 2014, Belgium was a net exporter on the vaccine market. Over the period under review, exports consistently exceeded imports in value terms. However, in physical terms, the difference was somewhat mitigated by high import prices.

Belgium's top 5 trading partners in 2014 were France, the U.S., Germany, the UK and Brazil, with a combined share 74.3% of Belgian exports. The share of France increased significantly (+25 percentage points), while the share of Germany illustrated negative dynamics (-8 percentage points).

France and Ireland were among the other main global suppliers of vaccines for human medicine in 2014. They were also among the fastest growing suppliers at 18% and 169% growth rates, respectively. With this impressive surge, Ireland greatly toned up its position in the global export structure.

Do you want to know more about the global vaccine market? Get the latest trends and insight from our report. It includes a wide range of statistics on

  • vaccine market share
  • vaccine prices
  • vaccine industry
  • vaccine sales
  • vaccine market forecast
  • vaccine price forecast
  • key vaccine producers

Source: World: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020